Stool collected on day 48 was positive for botulinum neurotoxin type A
by MBA on day 68.
Botulinum neurotoxin type A
for the treatment of pain: not just in migraine and trigeminal neuralgia.
Tamburin, "Botulinum neurotoxin type a
for the treatment of pain: not just in migraine and trigeminal neuralgia," Journal of Headache and Pain, vol.
The intraprostatic injection of botulinum neurotoxin type A
(BoNT-A) is a minimally invasive usage of the drug to treat benign prostatic hyperplasia (BPH) and subsequent lower urinary tract symptoms (LUTS).
The effects of purified botulinum neurotoxin type A
on cholinergic, adrenergic and non-adrenergic, atropine-resistant, autonomic neuromuscular transmission.
Johnson, "Comparison of the primary rat spinal cord cell (RSC) assay and the mouse bioassay for botulinum neurotoxin type A
potency determination," Journal of Pharmacological and Toxicological Methods, vol.
Early effect on the overactive bladder symptoms following botulinum neurotoxin type A
injections for detrusor overactivity.
Crystal structure of botulinum neurotoxin type A
and implications for toxicity.
Dott, "Botulinum neurotoxin type A
causes shifts in myosin heavy chain composition in muscle," Toxicon, vol.
-- Antibodies against botulinum toxins, led by XOMA 3AB, a novel combination of three antibodies to prevent and treat botulism poisoning caused by exposure to botulinum neurotoxin Type A
, among the most deadly bioterror threats.
The new cell-based potency assay for BOTOX and BOTOX Cosmetic is specific to Allergan's formulation of botulinum neurotoxin type A
Effects of purification on the bioavailability of botulinum neurotoxin type A
. Toxicology 2008; 249:123-9.